Becton Dickinson and Co
BDX · Healthcare · Health Care
Updated 27 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #222 of 500 by Iconic Score · #27 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Becton Dickinson and Co (BDX) is a leading global medical technology company specializing in the development and manufacturing of medical devices, instrument systems, and reagents. With a market capitalization of $42.3 billion, BDX operates primarily in the healthcare sector, providing essential products that facilitate drug delivery, diagnostics, and surgical procedures. The company is recognized for its innovation and commitment to improving patient outcomes, holding a strong market position due to its extensive product portfolio and established relationships with healthcare providers worldwide. BDX plays a critical role in enhancing healthcare efficiency and safety, making it a significant player in the ongoing evolution of medical technology and patient care solutions. Its focus on research and development positions it well to address emerging healthcare challenges and capitalize on growth opportunities in the sector.
IconicOracleAI™ Brief
Becton Dickinson and Co (BDX) currently holds an Iconic Score of 50, reflecting a stable brand presence amid mixed market sentiment. The company's brand visibility remains strong at 85/100, indicating effective logo recognition. Recent headlines, including comparisons to competitors like Boston Scientific, suggest a heightened focus on BDX's market position within the medical technology sector, contributing to ongoing discussions about its performance relative to peers.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.